SpringerPlus

4.5k papers and 80.7k indexed citations i.

About

The 4.5k papers published in SpringerPlus in the last decades have received a total of 80.7k indexed citations. Papers published in SpringerPlus usually cover Molecular Biology (635 papers), Surgery (460 papers) and Pulmonary and Respiratory Medicine (352 papers) specifically the topics of Breast Cancer Treatment Studies (86 papers), Sports Performance and Training (73 papers) and Fractional Differential Equations Solutions (69 papers). The most active scholars publishing in SpringerPlus are Chao‐Ying Joanne Peng, Emad͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏ Yousif, Raghad Haddad, Seema B. Sharma, Mrugesh H. Trivedi, R. Z. Sayyed, Jayme Garcia Arnal Barbedo, Li-Chen Chou, Mehjbeen Javed and Nazura Usmani.

In The Last Decade

Fields of papers published in SpringerPlus

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in SpringerPlus. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in SpringerPlus

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in SpringerPlus. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in SpringerPlus with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025